APO-GO 5mg / ml single-dose pre-filled syrup infusion solution medication leaflet

N04BC07 apomorphine • Nervous system | Dopaminergic agents | Dopamine agonists

Apomorphine is a dopamine receptor agonist used in the treatment of Parkinson's disease, particularly for managing motor block episodes (off episodes). It works by directly stimulating dopamine receptors in the brain, alleviating motor symptoms such as rigidity, tremor, and bradykinesia.

Apomorphine is administered as subcutaneous injections or through continuous infusion pumps, depending on the patient's needs. It is often used as a rescue therapy for patients who do not respond adequately to oral treatments.

Common side effects include nausea, vomiting, orthostatic hypotension, and drowsiness. In rare cases, allergic reactions or compulsive behaviors may occur. It is important for treatment to be initiated under strict medical supervision.

Apomorphine is a valuable therapeutic option for patients with Parkinson's disease, helping to improve quality of life by reducing motor block episodes.

General data about APO-GO 5mg / ml

Substance: apomorphine

Date of last drug list: 01-06-2025

Commercial code: W66227003

Concentration: 5mg / ml

Pharmaceutical form: single-dose pre-filled syrup infusion solution

Quantity: 50

Product type: original

Price: 5450.15 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ROVI CONTRACT MANUFACTURING, S.L. - SPANIA

Holder: STADA ARZNEIMITTEL AG - GERMANIA

Number: 12115/2019/03

Shelf life: 2 years-after packing for marketing; after the first opening-it is used immediately

Concentrations available for apomorphine

10mg/ml, 2mg, 3mg, 5mg/ml

Compensation lists for APO-GO 5mg / ml STADA

G12 (C1) - Parkinson's disease

Price

Copayment

Patient

5450.15 RON

5450.15 RON

0.00 RON